To our knowledge, this is the first time that the LOPAC® library has been used in the context of a random in vitro screening against ALS-related SOD1 variants for the discovery of inhibitors of its aggregation (protein–drug interaction). Here, SOD1 is linked to amyotrophic lateral sclerosis.